Cost-Effectiveness of Adult Universal Hepatitis B Vaccination

J Infect Dis. 2022 Dec 13;226(12):2239-2241. doi: 10.1093/infdis/jiac217.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Cost-Benefit Analysis
  • Cost-Effectiveness Analysis
  • Hepatitis B Vaccines
  • Hepatitis B* / prevention & control
  • Humans
  • Vaccination

Substances

  • Hepatitis B Vaccines